XAGE Multiplikator Forward P/S Carmell Therapeutics
The projected P/S of Longevity Health Holdings (XAGE) reflects the market valuation dynamics, where 3.90 represents the current level of the metric. Production is being automated through the implementation of robotic filling lines supervised by AI. Stable margins are ensured by high customer loyalty to plasma-based regeneration products. The premium positioning of biotechnological rejuvenation products allows the company to maintain high pricing power.
Rincian analitis perusahaan Carmell Therapeutics (XAGE)
- rega saiki lan proyeksi nilai saham:
- data kapitalisasi pasar:
- statistik nilai buku emiten:
- data utang lan likuiditas:
Rasio Total Utang marang Ekuitas Longevity Health Holdings|XAGE - Rasio silihan jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Carmell Corp|XAGE - Utang kumulatif perusahaan|Utang marang nilai buku Carmell Therapeutics Corporation|XAGE - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Longevity Health Holdings|Rasio cepet carmellcosmetics.com
- indikator pendapatan resik lan kelipatan nilai:
XAGE - Penghasilan resik perusahaan|Proyeksi bathi mangsa ngarep Longevity Health Holdings|XAGE - Pangali P/E|Rega marang bathi mangsa ngarep Longevity Health Holdings|XAGE - Rasio rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Carmell Corp|XAGE - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|Bathi resik saben saham (EPS TTM) Longevity Health Holdings|XAGE - Bathi saben saham sajroning taun lumaku|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan carmellcosmetics.com|XAGE - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Longevity Health Holdings
- indikator pendapatan dodolan lan penghasilan bisnis:
Analisis wiwitan perusahaan:Longevity Health Holdings Inc (XAGE)
For Longevity Health Holdings (XAGE), the forward P/S valuation synthesizes market capitalization and expected sales volume, reflecting the dynamics of the business's fundamental re-rating. The growth of this indicator reflects market confidence in the expansion into aesthetic cosmetics; however, weak operational efficiency and high scaling costs leave the asset vulnerable to a sharp liquidity squeeze should revenue targets not be met.
Pesaing wigati
Multiplikator Forward P/S HCA (HCA Healthcare, Inc.)|Rasio rega marang pendapatan sing dikarepake THC (Tenet Healthcare)|FMS - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep solventum.com|EHC: Multiplikator Forward P/S|UHS - Rasio kapitalisasi marang dodolan sing dikarepake|DVA (DaVita Corp) - Multiplikator Forward P/S|RDNT: Rega forward marang dodolan|Multiplikator Forward P/S OPCH|SGRY (surgerypartners.com) - Rega forward marang dodolan|Multiplikator Forward P/S PINC (Premier Inc)|National Vision - Rasio rega marang prakiraan pendapatan|PGNY - Rasio rega marang prakiraan pendapatan|ARDT - Multiplikator Forward P/S|SEM: Multiplikator Forward P/S|astranahealth.com (ASTH) - Multiplikator Forward P/S|MD (mednax.com) - Multiplikator Forward P/S|Multiplikator Forward P/S usph.com|Multiplikator Forward P/S PNTG|Rasio kapitalisasi marang dodolan sing dikarepake Organogenesis Holdings|Multiplikator Forward P/S NUTX (nutexhealth.com)|Auna SA (AUNA) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|SBC: Multiplikator forward rega marang pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake Jeuveau EOLS|CYH (Community Health Systems Inc) - Multiplikator forward rega marang pendapatan|SKIN: Rasio rega marang pendapatan sing dikarepake|Multiplikator forward rega marang pendapatan MDWD|BTMD: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan The Joint Corporation (JYNT)|Multiplikator Forward P/S DocGo Inc (DCGO)|Rega forward marang dodolan P3 Health Partners, Inc.|Rasio kapitalisasi marang dodolan sing dikarepake gaintherapeutics.com (GANX)|EUDA: Multiplikator forward rega marang pendapatan|BMGL: Rasio rega marang prakiraan pendapatan|collplant.com (CLGN) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan Cuprina Holdings|CCM (concordmedical.com) - Multiplikator Forward P/S|Multiplikator Forward P/S ASHS|Rasio rega marang prakiraan pendapatan MEDIROM (MRM)|ALBT - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|DIH Holding US, Inc. - Multiplikator forward rega marang pendapatan|NIVF: Kapitalisasi marang prakiraan pendapatan|ATIP: Multiplikator forward rega marang pendapatan|CareMax Medical Group - Rasio rega marang pendapatan sing dikarepake|Kindly MD (KDLY) - Rasio rega marang prakiraan pendapatan|Kapitalisasi marang prakiraan pendapatan MODV|Rasio rega marang prakiraan pendapatan Novo Integrated Sciences Corp|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep SunLink Health Systems SSY|Rasio rega marang prakiraan pendapatan IMAC Corp (BACK)
